350 related articles for article (PubMed ID: 19543640)
1. [Clinical and metabolic features of subjects with glucose intolerance and high fasting glucose levels].
Arteaga Llona A; Pollak F; Robres L; Velasco N
Rev Med Chil; 2009 Feb; 137(2):193-9. PubMed ID: 19543640
[TBL] [Abstract][Full Text] [Related]
2. [Evaluation of islet beta cell function in subjects with normal glucose tolerance, impaired glucose regulation, and type 2 diabetes mellitus].
Liu J; Li YB; Shao H; Li YX; Yuan YH; Xiao YB; Weng JP
Zhonghua Yi Xue Za Zhi; 2007 May; 87(18):1252-5. PubMed ID: 17686259
[TBL] [Abstract][Full Text] [Related]
3. Insulin resistance, beta cell function and cardiovascular risk factors in Ghanaians with varying degrees of glucose tolerance.
Amoah AG; Schuster DP; Gaillard T; Osei K
Ethn Dis; 2002; 12(4):S3-10-7. PubMed ID: 12477148
[TBL] [Abstract][Full Text] [Related]
4. Impact of traits of metabolic syndrome on β-cell function and insulin resistance in normal fasting, normal glucose tolerant subjects.
Cubeddu LX; Hoffmann IS
Metab Syndr Relat Disord; 2012 Oct; 10(5):344-50. PubMed ID: 22803772
[TBL] [Abstract][Full Text] [Related]
5. Metabolic characteristics of subjects with normal glucose tolerance and 1-h hyperglycaemia.
Qian L; Fu X; Xu L; Zheng S; Zhou W; Wang X; Gu Y; Lin F; Luo M
Clin Endocrinol (Oxf); 2008 Oct; 69(4):575-9. PubMed ID: 18248638
[TBL] [Abstract][Full Text] [Related]
6. Insulin sensitivity and secretion in Arab Americans with glucose intolerance.
Salinitri FD; Pinelli NR; Martin ET; Jaber LA
Diabetes Technol Ther; 2013 Dec; 15(12):1019-24. PubMed ID: 23919587
[TBL] [Abstract][Full Text] [Related]
7. Insulin resistance, beta-cell function, and glucose tolerance in Brazilian adolescents with obesity or risk factors for type 2 diabetes mellitus.
da Silva RC; Miranda WL; Chacra AR; Dib SA
J Diabetes Complications; 2007; 21(2):84-92. PubMed ID: 17331856
[TBL] [Abstract][Full Text] [Related]
8. Elevated 1-hour postload plasma glucose levels identify subjects with normal glucose tolerance but impaired β-cell function, insulin resistance, and worse cardiovascular risk profile: the GENFIEV study.
Bianchi C; Miccoli R; Trombetta M; Giorgino F; Frontoni S; Faloia E; Marchesini G; Dolci MA; Cavalot F; Cavallo G; Leonetti F; Bonadonna RC; Del Prato S;
J Clin Endocrinol Metab; 2013 May; 98(5):2100-5. PubMed ID: 23539736
[TBL] [Abstract][Full Text] [Related]
9. Serum gamma-glutamyltransferase levels are related to insulin sensitivity and secretion in subjects with abnormal glucose regulation.
Bianchi C; Penno G; Crisci I; Daniele G; Agostini A; Del Prato S; Miccoli R
Diabetes Metab Res Rev; 2010 Mar; 26(3):181-6. PubMed ID: 20186999
[TBL] [Abstract][Full Text] [Related]
10. Insulin resistance and fasting plasma glucose in first degree relatives of patients with type 1 diabetes.
Siewko K; Popławska-Kita A; Telejko B; Maciulewski R; Zielińska A; Nikołajuk A; Górska M; Szelachowska M
J Diabetes Complications; 2013; 27(6):593-6. PubMed ID: 23890682
[TBL] [Abstract][Full Text] [Related]
11. [Insulin secretion and insulin sensitivity in subjects with impaired fasting glucose].
Nishi Y; Yamada Y; Fukushima M; Seino Y
Nihon Rinsho; 2005 Feb; 63 Suppl 2():151-4. PubMed ID: 15779360
[No Abstract] [Full Text] [Related]
12. [Replacement of insulin by fasting C-peptide in modified homeostasis model assessment to evaluate insulin resistance and islet beta cell function].
Li X; Zhou ZG; Qi HY; Chen XY; Huang G
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2004 Aug; 29(4):419-23. PubMed ID: 16134594
[TBL] [Abstract][Full Text] [Related]
13. Risk of future diabetes is as high with abnormal intermediate post-glucose response as with impaired glucose tolerance.
Viswanathan V; Clementina M; Nair BM; Satyavani K
J Assoc Physicians India; 2007 Dec; 55():833-7. PubMed ID: 18405128
[TBL] [Abstract][Full Text] [Related]
14. Impaired early- but not late-phase insulin secretion in subjects with impaired fasting glucose.
Kanat M; Norton L; Winnier D; Jenkinson C; DeFronzo RA; Abdul-Ghani MA
Acta Diabetol; 2011 Sep; 48(3):209-17. PubMed ID: 21553243
[TBL] [Abstract][Full Text] [Related]
15. Beta-cell dysfunction in subjects with impaired glucose tolerance and early type 2 diabetes: comparison of surrogate markers with first-phase insulin secretion from an intravenous glucose tolerance test.
Festa A; Williams K; Hanley AJ; Haffner SM
Diabetes; 2008 Jun; 57(6):1638-44. PubMed ID: 18332099
[TBL] [Abstract][Full Text] [Related]
16. Metabolic characteristics of glucose intolerance: the critical role of obesity.
Sainaghi PP; Castello L; Bergamasco L; Carnevale Schianca GP; Bartoli E
Exp Clin Endocrinol Diabetes; 2008 Feb; 116(2):86-93. PubMed ID: 17972239
[TBL] [Abstract][Full Text] [Related]
17. [Role of insulin resistance and β cell function in the development of newly diagnosed type 2 diabetes].
Chen X; Su M; Wang C; Wu Z; Li S; Ying X; Wei G; Fu C; Jiang Q
Wei Sheng Yan Jiu; 2015 Nov; 44(6):881-6. PubMed ID: 26738376
[TBL] [Abstract][Full Text] [Related]
18. Rosiglitazone improves insulin sensitivity in nonobese subjects with impaired glucose tolerance: the role of adiponectin and C-reactive protein.
Hung YJ; Lin SH; Pei D; Kuo SW; Hsieh CH; He CT; Hsing Lee C; Fan SC; Sheu WH
Metabolism; 2006 Apr; 55(4):439-44. PubMed ID: 16546473
[TBL] [Abstract][Full Text] [Related]
19. Insulin function in obese children within the low and high ranges of impaired fasting glycemia.
Hagman E; Ek AE; Marcus C
Pediatr Diabetes; 2019 Mar; 20(2):160-165. PubMed ID: 30537059
[TBL] [Abstract][Full Text] [Related]
20. The metabolic responses induced by acute dexamethasone predict glucose tolerance and insulin secretion over 10 years in relatives of type 2 diabetic subjects.
Durck TT; Henriksen JE; Egede MB; Levin K; Rantzau C; Ward G; Beck-Nielsen H; Alford FP
Diabetes Metab Res Rev; 2013 Sep; 29(6):492-8. PubMed ID: 23568564
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]